Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Jun;10(6):2478–2492. doi: 10.21037/tau-21-445

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

2021 Translational Andrology and Urology. All rights reserved.

Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0.

PMC Copyright notice

Immune cells that affect the OS of patients with CCRCC, and their correlations with risk score. Kaplan-Meier survival analysis of resting dendritic cells (A), resting mast cells (B) and resting memory CD4 T cells (C), M0 macrophages (D), plasma cells (E), follicular helper T cells (F), and Tregs (G). Correlation analysis of risk score and resting dendritic cells (H), resting mast cells (I), resting memory CD4 T cells (J), M0 macrophages (K), plasma cells (L), follicular helper T cells (M), and Tregs (N). OS, overall survival; CCRCC, kidney renal clear cell carcinoma; Tregs, regulatory T cells.